STOCK TITAN

Ethema Hlth - GRST STOCK NEWS

Welcome to our dedicated page for Ethema Hlth news (Ticker: GRST), a resource for investors and traders seeking the latest updates and insights on Ethema Hlth stock.

Overview

Ethema Health Corporation (symbol: GRST) operates within the behavioral healthcare sector with a specialized focus on the treatment of substance use disorders. With a unique clinical approach honed over the past decade, the Company has developed innovative inpatient treatment programs for adults, cementing its reputation as an expert in addressing complex behavioral health needs. Leveraging proven therapeutic methods and robust operational management, Ethema Health delivers high-quality care to patients, notably those relying on Medicaid and other in-network insurance strategies, ensuring that clinical outcomes and client safety remain paramount.

Core Business and Clinical Programs

The core business of Ethema Health centers on the provision of inpatient detoxification, residential treatment services, and partial hospitalization programs. The Company’s treatment centers are strategically located in key markets across Florida and Kentucky, serving diverse patient populations. In its inpatient units, innovative detoxification protocols and residential care methodologies are implemented to address substance use disorders effectively. The clinical protocols are continuously refined based on emerging best practices, ensuring that treatment programs remain comprehensive and responsive to patient needs.

Operational Strategy and Asset Management

Ethema Health not only focuses on delivering exceptional clinical care but also employs a sophisticated operational strategy that includes strategic asset acquisitions and effective real estate management. A notable example is the Company’s management and eventual acquisition of operations from Edgewater Recovery Center (ERC) in Kentucky. Through such transactions, the Company has integrated over 400 licensed beds in key urban centers, thereby expanding its operational capacity and geographical footprint. In addition, Ethema Health utilizes sale-leaseback transactions to unlock working capital from its real estate assets, enabling further growth without necessitating new equity issuance.

Integrated Business Model

The Company’s business model integrates patient care with astute asset and operational management. Revenue is generated primarily through patient services delivered in fully licensed, state-regulated treatment centers. Ethema Health’s focus on managing complex assets—from direct facility management to structured acquisitions—illustrates its aptitude in deploying both clinical and financial strategies. The seamless interplay between clinical operations and real estate strategy allows the Company to maintain operational agility, meet patient demands, and optimize its cost structure, thereby enhancing overall market competitiveness.

Market Position and Competitive Landscape

Operating in a competitive healthcare environment, Ethema Health distinguishes itself by merging longstanding clinical excellence with innovative asset management. Its strategic decisions—to acquire operating assets, secure key licenses, and maintain a diverse portfolio of treatment facilities—underline its commitment to sustainable business practices. In markets like Florida and Kentucky, where competition is robust, the Company has successfully positioned itself to serve underserved segments, particularly among Medicaid recipients. By focusing on clinical integrity and operational efficiency, Ethema Health builds confidence among stakeholders and reflects its deep industry expertise.

Regulatory and Licensing Excellence

Compliance with regulatory requirements is a cornerstone of Ethema Health’s operational philosophy. The Company ensures that all treatment centers meet or exceed state licensing standards, as demonstrated by its recent experiences in rapidly obtaining certifications for new facilities. These efforts underscore its ability to navigate complex healthcare regulations while maintaining uninterrupted patient services. Furthermore, the Company’s proactive stance in addressing and managing compliance risks further elevates its profile among industry regulators and payers.

Commitment to Quality and Patient Outcomes

Ethema Health has built its reputation on a steadfast commitment to patient care and clinical excellence. By focusing on individualized treatment plans, employing experienced clinical teams, and incorporating robust operational practices, the Company ensures that each treatment facility delivers reliable, safe, and influential care. The emphasis on quality programming and data-driven treatment approaches forms the backbone of its strategy in generating positive long-term outcomes for patients.

Strategic Expansion and Real Estate Initiatives

In addition to its clinical operations, Ethema Health is actively expanding through strategic real estate initiatives. Beyond traditional facility expansion, the Company is exploring real estate funds designed to leverage undervalued assets through sale-leaseback transactions. This integrated approach to asset management not only strengthens the balance sheet but also contributes to ongoing operational flexibility. Such initiatives enable the Company to balance growth with financial prudence, ensuring that it can scale operations while maintaining sound fiscal management practices.

Holistic Operational Excellence

The integrated business model of Ethema Health is underpinned by its capability to combine therapeutic expertise with advanced operational strategies. From managing complex transactions in the asset acquisition space to overseeing regulatory compliance and patient-focused care, every aspect of the business is meticulously aligned with a central goal: to offer reliable, high-quality treatment for substance use disorders. This multifaceted approach provides a robust foundation that positions the Company as an informed and effective operator in a challenging industry.

Conclusion

In summary, Ethema Health Corporation embodies a balanced blend of clinical excellence and operational savvy. With a clear focus on substance use disorder treatment for adults, a strategic approach to asset management, and a commitment to regulatory and clinical integrity, the Company presents a comprehensive model that addresses both immediate patient needs and long-term operational stability. Its differentiated approach, characterized by innovative inpatient programs and dynamic real estate initiatives, makes Ethema Health a notable participant in the behavioral healthcare landscape.

Rhea-AI Summary

Ethema Health (OTCPINK:GRST) has announced its participation in The Microcap Conference 2025, scheduled for January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ. This premier event brings together growth-focused companies and investors.

The company's management team will deliver a corporate presentation and conduct one-on-one meetings with institutional and individual investors. During these sessions, they will discuss recent developments, growth strategy, and investment opportunities.

Notably, Ethema has exceeded all projections made at the 2024 Microcap conference. Mr. Leon will present details about the significant impact of the company's recently acquired Kentucky business and outline the outlook for 2025 and beyond.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Ethema Health 's subsidiary ARIA received a full license for inpatient detoxification and Residential Level 1 facility in Boca Raton on October 21, 2024. The ARIA Boca facility features 11 detox beds and 12 residential beds, increasing total Florida bed count to 85. While Q3 revenue from ARIA Boca was delayed pending insurer contract updates, ARIA's Q3 2024 revenues grew 18% from Q2 2024 and 30% from Q3 2023. The company expects ARIA Boca revenue generation in Q4 2024 and plans to complete the Edgewater Recovery center acquisition in Kentucky during the same quarter. Management aims for an uplisting in H1 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Ethema Health (OTCPINK: GRST) has signed a binding Asset Purchase Agreement to acquire the business operations and operational assets of Edgewater Recovery Center, (ERC) in Kentucky. The transaction excludes real property and requires various consents. ERC has been managed by Ethema since July 15, 2024, and will continue operations until ARIA Kentucky, a new subsidiary, is fully licensed and accredited.

The current ERC patient census is approximately 195 patients, with expectations of significant growth. Ethema plans to add 16 beds in October at the Paducah location. ARIA Kentucky will primarily serve Medicaid-insured clients, with potential for expansion due to ongoing investigations into other Medicaid providers in the state.

The real property associated with ERC operations will be acquired separately by a fund controlled by Ethema's CEO, Shawn Leon, and leased to ARIA Kentucky at market rates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Ethema Health (OTCPINK: GRST) has received a license for its new 16-bed inpatient detoxification and 16-bed residential level 1 facility in Boca Raton, Florida. This increases the company's total bed count in Florida to 94. Ethema is also negotiating to purchase facilities in Kentucky, potentially adding 60 more beds.

The company is considering setting up a separate Real Estate Fund and plans to announce a new Preferred Stock offering. CEO Shawn Leon will present at the 1640 Society gathering in Southampton, New York. Ethema has reset its growth target to 3,000 beds by the end of 2027. The company is also discussing potential up-listing, a convertible preferred stock offering, and future cash dividends.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.5%
Tags
none
-
Rhea-AI Summary

Ethema Health (OTCPINK: GRST) is set to present at the Emerging Growth Healthcare Conference on July 18, 2024 at 10:15 AM Eastern time. CEO Shawn Leon will discuss the company and the effects of the recently announced LOI for the purchase and management of Edgewater Recovery Center .

The live, interactive online event allows shareholders and investors to engage with the CEO in real-time. Attendees can submit questions in advance or during the event. Registration is required to attend and receive updates.

Additionally, Shawn Leon was interviewed by SaveChangeWorld.com on July 14, 2024, primarily discussing Ethema's acquisition of Edgewater Recovery Center. The recorded interview, available on their website, includes projections and Ethema's ongoing financing strategy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Ethema Health (GRST) has signed a Letter of Intent (LOI) to acquire all assets of Edgewater Recovery Center (ERC), including three real estate holding companies. The agreement also includes a management deal effective July 15, 2024, until the acquisition closes on January 31, 2025. ERC operates in Morehead and Paducah, Kentucky, with around 440 licensed beds and an additional 66 beds coming online in 2024. The acquisition is expected to help Ethema reach its goal of 500 beds by the end of 2025. The deal will also allow Ethema to pursue a sale-leaseback transaction for working capital without new equity. Ethema’s CEO, Shawn Leon, highlighted the strategic benefits, including expanding Medicaid-insured care and up-listing plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.67%
Tags
none
Rhea-AI Summary
Ethema Health Corporation (GRST) will be giving a live update at the next Emerging Growth Conference on February 8, 2024. The CEO will provide an update on the previous presentation and answer questions from shareholders and the investment community. The company also presented at the Deal Flow Microcap Conference and received unanimous support for its growth plans.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences acquisition
-
Rhea-AI Summary
Ethema Health Corporation, ticker symbol GRST, will be participating in The Microcap Conference on January 30, 31, and February 1, 2024, with CEO Shawn Leon presenting on January 31 & February 1. The event will take place at Caesars Atlantic City Hotel & Casino in Atlantic City, NJ. Interested parties can register to attend and have one-on-one meetings with the management team.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Ethema Health Corporation (GRST) has been invited to present at the next Emerging Growth Conference, giving shareholders and the investment community the opportunity to interact with the Company’s CEO Shawn Leon. Mr. Leon will present Ethema’s outlook for 2024 and answer questions during the live, interactive online event on January 10 and 11, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences acquisition
Rhea-AI Summary
Ethema Health Corporation (GRST) reported a significant improvement in financial performance in the third quarter of 2023, with a net income of $1,529,599 for the nine months ended September 30, 2023, compared to a net loss of $167,162 for the same period in 2022. The company attributes this increase to profits from the purchase and sale of its real estate leased by its ARIA subsidiary. ARIA subsidiary's EBITDA for the nine months ended September 30, 2023, was $883,603, and the Company's wholly owned subsidiary, PB Billing LLC, reported an EBITDA of $50,860. The CEO, Mr. Shawn Leon, expressed satisfaction with the significant income numbers, balance sheet improvement, and debt reduction. The company is also focused on raising new equity investment through its Reg A+ offering and new strategic partners, priced above the current market prices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Ethema Hlth (GRST)?

The current stock price of Ethema Hlth (GRST) is $0.0004 as of April 15, 2025.

What is the market cap of Ethema Hlth (GRST)?

The market cap of Ethema Hlth (GRST) is approximately 3.5M.

What is the primary focus of Ethema Health Corporation?

Ethema Health Corporation specializes in the treatment of substance use disorders, offering innovative inpatient detoxification and residential care services.

How does Ethema generate revenue?

The Company primarily generates revenue through patient service billing in its licensed treatment facilities, supported by strategic asset acquisition and management strategies.

What markets does Ethema Health operate in?

Ethema Health operates in key markets including Florida and Kentucky, addressing the needs of diverse patient populations through its network of treatment centers.

How does the company integrate real estate into its business model?

Ethema Health leverages real estate through transactions such as sale-leasebacks and strategic acquisitions, allowing the Company to unlock working capital while managing essential treatment facilities.

What distinguishes Ethema Health from its competitors?

The Company distinguishes itself by combining clinical excellence with strategic operational management, achieving a balance between high-quality patient care and astute asset management.

How does Ethema maintain regulatory compliance?

Ethema Health ensures strict adherence to state licensing and regulatory requirements, continuously updating its clinical and operational protocols to meet or exceed industry standards.

What role does Medicaid play in the Company’s operations?

Medicaid plays a significant role, particularly in the Kentucky operations, where a large segment of patients are Medicaid insured, aligning with the Company’s in-network insurance strategies.

How does Ethema plan to expand its operations?

The Company is expanding its operational footprint through strategic acquisitions and real estate initiatives, integrating additional treatment centers into its portfolio while focusing on clinical excellence and operational efficiency.
Ethema Hlth

OTC:GRST

GRST Rankings

GRST Stock Data

3.48M
3.57B
53.86%
Medical Care Facilities
Healthcare
Link
United States
West Palm Beach